The Role of Multivitamins in Pediatric HIV Management in Nigeria
Launched by REGINA ESIOVWA · Sep 16, 2015
Trial Information
Current as of April 25, 2025
Unknown status
Keywords
ClinConnect Summary
The link between micronutrient deficiencies and advanced HIV disease has been reported. Micronutrient deficiencies in people living with HIV/AIDS (PLWHA) have been linked to reduced antioxidant levels and oxidative stress. In turn oxidative stress is believed to promote HIV disease progression. The use of multivitamins in PLWHA therefore has the potential to cut off the interconnections between micronutrient deficiencies and HIV disease progression. If beneficial, multivitamin use in PLWHA could result in improved health outcomes.
A number of studies have explored this possibility with dif...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Children aged 5 - 12 years attending the outpatient clinic of the two HIV treatment centers who have tested positive to HIV
- • 2. Children who can return for follow up during the 6 months of the study
- • 3. Children with guardians who can give informed consent -
- Exclusion Criteria:
- • 1. Children enrolled in other studies
- • 2. Guardians and children anticipating moving away from the study state
- • 3. Children receiving immunosuppressive therapy
- • -
About Regina Esiovwa
Regina Esiovwa is a dedicated clinical trial sponsor committed to advancing medical research and enhancing patient care through innovative clinical studies. With a strong focus on ethical practices and robust methodologies, Regina Esiovwa collaborates with leading healthcare professionals and organizations to develop and implement trials that address critical health challenges. Their mission is to facilitate the discovery of safe and effective treatments, ensuring that patient safety and scientific integrity remain at the forefront of their initiatives. Through a commitment to excellence and transparency, Regina Esiovwa aims to contribute significantly to the field of clinical research and ultimately improve health outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Regina Esiovwa
Principal Investigator
University of the West of Scotland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials